-
Chapter 1
Colorectal Cancer Epidemiology
Authors: Pedro J Tarraga Lopez, Juan Solera Albero, Jose Antonio Rodriguez MontesCancer is a worldwide full-scale problem as it will affect one in three men and one in four women during their lifetime.
-
Chapter 2
Colorectal Cancer: Risk Factors and Prevention, Detection of Colorectal Cancer
Authors: Pedro J Tarraga Lopez, Juan Solera Albero, Jose Antonio Rodriguez MontesEpidemiology studies, especially chose of time trends and migrations studies, confirm the importance of envirommental factors in the etiology of colorectal cancer. Thus, corrections of these may reduce its incidence.
-
Chapter 3
Hereditary Colorectal Cancer Syndromes
Authors: Taina T Nieminen, Satu Valo, Noora PorkkaColorectal Cancer (CRC) is among the three most common cancers worldwide.
-
Chapter 4
Treatment of Colorectal Cancer Liver Metastases: Clinical and Molecular Aspects
Authors: Esin ECE, Saadettin KILIÇKAP, Aykut ÖZGÜR, Yusuf TUTARColorectal Cancer (CRC) is one of the common cancer types and a great proportion of the CRC patients develop metastasis to liver.
-
Chapter 5
Treatment of Rectal Cancer
Authors: Ahmed M ElSharkawyGlobally, rectal cancer is a major health problem with increasing incidence.
-
Chapter 6
Familial colorectal cancer type X (FCCX)
Authors: Taina T NieminenColorectal Cancer (CRC) is among the three most common cancers worldwide.
-
Chapter 7
Treatment of Colon Cancer
Authors: Mehmet R TOPÇUL , İdil ÇETİNSurgery, radiotherapy and chemotherapy are conventional methods used in colorectal cancer as with other types of cancers.
-
Chapter 8
Treatment of colorectal cancer Pulmonary Metastas
Authors: Tony IbrahimThe lung is the second most common site of colorectal cancer metastasis.
Promote this Book
How to link?
Copy the following HTML and paste it in your blog post or your web page.
Dr. Ralph Schneider
Department of Visceral, Thoracic and Vascular Surgery, Philipps University Marburg, Germany
Dr. Ralph Schneider is surgeon at the Center for Hereditary Tumor Syndromes“at the HELIOS Klinikum Wuppertal in Germany, which is the University hospital of the University Witten/Herdecke. His main clinical and research interests are hereditary tumor syndromes like FAP, Lynch syndrome or Peutz-Jeghers-syndrome. Within the last years he published several original papers and review in the field. PD Dr. Schneider studied medicine at the University of Regensburg and worked at the Military Hospital in Koblenz and at the Philipp’s University of Marburg. Since2014 he works together with Professor Gabriela Möslein - one of the leading scientists in the field of hereditary cancer worldwide.